Deferasirox Tablet, For Suspension
Product Images NDC 43598-855

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 43598-855). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Container1 (Container1)

Container1 (Container1)
This is a medication label for oral suspension, with a dosage of 30 tablets, which is distributed by the company Dr. Reddy's. The medication needs to be stored at room temperature and protected from moisture. The label includes a warning to keep the medication out of reach of children. No further information is available.*
FDA Label Image

Container2 (Container2)

Container2 (Container2)
Deferasirox Tablets for Oral Suspension is a medication that comes in tablet form, with 250 mg per tablet. It must be dispersed in water, orange juice, or apple juice before use, and it is intended for oral consumption. The tablets must be stored at a temperature between 20°C and 26°C, although temperatures between 5°C and 30°C are permitted. The medication should be kept away from moisture and out of reach of children. The product is distributed by Dr. Reddy's Laboratories Inc. in Princeton, NJ 08540 and was made in India. Dosage information is available in the prescribing information. The text also includes various identification numbers for the medication.*
FDA Label Image

Container3 (Container3)

Container3 (Container3)
FDA Label Image

Fig-01 (Deferasirox Figure 1)

Fig-01 (Deferasirox Figure 1)
This text contains data related to iron levels in the body and the administration of Deferasirox tablets in doses based on mg/kg/day to regulate these levels. It also describes changes in serum ferritin levels, providing information on the effectiveness of the medication.*
FDA Label Image

Str (Deferasirox Structure)

Str (Deferasirox Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.